100 Percent Fed Up By Danielle
GlaxoSmithKline (GSK) has sued Pfizer and BioNTech, accusing the COVID-19 jab manufacturers of infringing patents related to mRNA technology in the experimental shots.
“GSK Biologicals is the sole owner and assignee of numerous United States patents directed to formulations comprising lipids and messenger ribonucleic acid (‘mRNA’) molecules encoding an immunogen, and methods of administering the same,” the lawsuit read.
“In 2008, more than a decade before the SARS-CoV-2 (2019) coronavirus disease (COVID-19) pandemic, Andrew Geall, an accomplished formulation scientist and the named inventor of the Patents-in-Suit, joined a team of talented researchers working under the leadership of vaccinologist Christian Mandl (the ‘Mandl team’) focused on developing mRNA vaccines. These individuals discovered formulations comprising lipids and mRNA molecules encoding a viral immunogen that provide protection from viral infection. The Mandl team described the inventions now claimed in the Patents-in-Suit, in patent applications filed in 2010,” it continued.
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology.
Saw this coming from a mile away!
Lawsuit can be read here: https://t.co/x4tslToaud
— Brook Jackson 💜 (@IamBrookJackson) April 25, 2024
Per Reuters:
A Pfizer spokesperson said in a statement that the company is “confident in our IP position around Comirnaty” and intends to “vigorously defend” against GSK’s claims. A BioNTech spokesperson declined to comment on the complaint.
A GSK spokesperson said the company believes its patents “provided the foundational technology used in Pfizer and BioNTech’s COVID-19 mRNA vaccines,” and that it is “willing to license these patents on commercially reasonable terms and to ensure continued patient access” to the shots…
READ FULL ARTICLE HERE… (100percentfedup.com)
Home | Caravan to Midnight (zutalk.com)
